| | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H13N |
| Molar mass | 195.265 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
SIB-1893 is a drug used in scientific research which was one of the first compounds developed that acts as a selective antagonist for the metabotropic glutamate receptor subtype mGluR5. [1] It has anticonvulsant and neuroprotective effects, [2] and reduces glutamate release. [3] It has also been found to act as a positive allosteric modulator of mGluR4. [4]